SiMMap: A web server for inferring site-moiety map to recognize interaction preferences between protein pockets and compound moieties

Nucleic Acids Research

Volumn 38, Issue SUPPL. 2, 2010, Pages

  Chen, Yen Fu ^a   Hsu, Kai Cheng ^a   Lin, Shen Rong ^a   Wang, Wen Ching ^b   Huang, Yu Chi ^a   Yang, Jinn Moon ^a  

^a NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTROGEN DERIVATIVE; ESTROGEN RECEPTOR; PROTEIN; THYMIDINE KINASE; LIGAND;

ARTICLE; BINDING SITE; COMPUTER PROGRAM; CRYSTALLIZATION; HYDROGEN BOND; LIGAND BINDING; MOLECULAR DOCKING; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN BINDING; STATIC ELECTRICITY; WEB BROWSER; AGONISTS; ANTAGONISTS AND INHIBITORS; CHEMISTRY; COMPUTER INTERFACE; DRUG DEVELOPMENT; INTERNET;

BINDING SITES; DRUG DISCOVERY; INTERNET; LIGANDS; PROTEINS; RECEPTORS, ESTROGEN; SOFTWARE; THYMIDINE KINASE; USER-COMPUTER INTERFACE;

EID: 77954249073     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkq480     Document Type: Article

References (29)

1. Hajduk,P.J. and Greer,J. (2007) A decade of fragment-based drug design: strategic advances and lessons learned. Nat. Rev. Drug. Discov., 6, 211-219.
2. Kitchen,D.B., Decornez,H., Furr,J.R. and Bajorath,J. (2004) Docking and scoring in virtual screening for drug discovery: methods and applications. Nat. Rev. Drug Discov., 3, 935-949.
3. Lyne,P.D. (2002) Structure-based virtual screening: an overview. Drug Discov. Today, 7, 1047-1055.
4. Tanrikulu,Y. and Schneider,G. (2008) Pseudoreceptor models in drug design: bridging ligand-and receptor-based virtual screening. Nat. Rev. Drug Discov., 7, 667-677.
5. Ewing,T.J., Makino,S., Skillman,A.G. and Kuntz,I.D. (2001) DOCK 4.0: search strategies for automated molecular docking of flexible molecule databases. J. Comput. Aided Mol. Des., 15, 411-428.
6. Jones,G., Willett,P., Glen,R.C., Leach,A.R. and Taylor,R. (1997) Development and validation of a genetic algorithm for flexible docking. J. Mol. Biol., 267, 727-748.
7. Kramer,B., Rarey,M. and Lengauer,T. (1999) Evaluation of the FLEXX incremental construction algorithm for protein-ligand docking. Proteins, 37, 228-241.
8. Yang,J.M. and Chen,C.C. (2004) GEMDOCK: a generic evolutionary method for molecular docking. Proteins, 55, 288-304.
9. An,J., Lee,D.C., Law,A.H., Yang,C.L., Poon,L.L., Lau,A.S. and Jones,S.J. (2009) A novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase. J. Med. Chem., 52, 2667-2672.
10. Hung,H.C., Tseng,C.P., Yang,J.M., Ju,Y.W., Tseng,S.N., Chen,Y.F., Chao,Y.S., Hsieh,H.P., Shih,S.R. and Hsu,J.T. (2009) Aurintricarboxylic acid inhibits influenza virus neuraminidase. Antiviral Res., 81, 123-131.
11. Powers,R.A., Morandi,F. and Shoichet,B.K. (2002) Structure-based discovery of a novel, noncovalent inhibitor of AmpC beta-lactamase. Structure, 10, 1013-1023.
12. Schapira,M., Raaka,B.M., Das,S., Fan,L., Totrov,M., Zhou,Z., Wilson,S.R., Abagyan,R. and Samuels,H.H. (2003) Discovery of diverse thyroid hormone receptor antagonists by high-throughput docking. Proc. Natl Acad. Sci. USA, 100, 7354-7359.
13. Yang,J.M., Chen,Y.F., Tu,Y.Y., Yen,K.R. and Yang,Y.L. (2007) Combinatorial computational approaches to identify tetracycline derivatives as flavivirus inhibitors. PLoS ONE, 2, e428.
14. Yang,J.M. and Shen,T.W. (2005) A pharmacophore-based evolutionary approach for screening selective estrogen receptor modulators. Proteins, 59, 205-220.
15. Pan,Y., Huang,N., Cho,S. and MacKerell,A.D. Jr (2003) Consideration of molecular weight during compound selection in virtual target-based database screening. J. Chem. Inform. Comp. Sci., 43, 267-272.
16. Tafi,A., Bernardini,C., Botta,M., Corelli,F., Andreini,M., Martinelli,A., Ortore,G., Baraldi,P.G., Fruttarolo,F., Borea,P.A. et al. (2006) Pharmacophore based receptor modeling: the case of adenosine A3 receptor antagonists. An approach to the optimization of protein models. J. Med. Chem., 49, 4085-4097.
17. Champness,J.N., Bennett,M.S., Wien,F., Visse,R., Summers,W.C., Herdewijn,P., de Clerq,E., Ostrowski,T., Jarvest,R.L. and Sanderson,M.R. (1998) Exploring the active site of herpes simplex virus type-1 thymidine kinase by X-ray crystallography of complexes with aciclovir and other ligands. Proteins, 32, 350-361.
18. Shiau,A.K., Barstad,D., Loria,P.M., Cheng,L., Kushner,P.J., Agard,D.A. and Greene,G.L. (1998) The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell, 95, 927-937.
19. Warnmark,A., Treuter,E., Gustafsson,J.A., Hubbard,R.E., Brzozowski,A.M. and Pike,A.C. (2002) Interaction of transcriptional intermediary factor 2 nuclear receptor box peptides with the coactivator binding site of estrogen receptor alpha. J. Biol. Chem., 277, 21862-21868.
20. Bissantz,C., Folkers,G. and Rognan,D. (2000) Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. J. Med. Chem., 43, 4759-4767.
21. Yang,M.-C., Guan,H.-H., Yang,J.-M., Ko,C.-N., Liu,M.-Y., Lin,Y.-H., Chen,C.-J. and Mao,S.J.T. (2008) Rational design for crystallization of beta-lactoglobulin and vitamin D-3 complex: revealing a secondary binding site. Crystal Growth Design, 8, 4268-4276.
22. Chin,K.H., Lee,Y.C., Tu,Z.L., Chen,C.H., Tseng,Y.H., Yang,J.M., Ryan,R.P., McCarthy,Y., Dow,J.M., Wang,A.H. et al. (2010) The cAMP receptor-like protein CLP is a novel c-di-GMP receptor linking cell-cell signaling to virulence gene expression in Xanthomonas campestris. J. Mol. Biol., 396, 646-662.
23. Yang,J.M., Chen,Y.F., Shen,T.W., Kristal,B.S. and Hsu,D.F. (2005) Consensus scoring criteria for improving enrichment in virtual screening. J. Chem. Inf. Model, 45, 1134-1146.
24. Kussmann-Gerber,S., Kuonen,O., Folkers,G., Pilger,B.D. and Scapozza,L. (1998) Drug resistance of herpes simplex virus type 1-structural considerations at the molecular level of the thymidine kinase. Eur. J. Biochem., 255, 472-481.
25. Wild,K., Bohner,T., Folkers,G. and Schulz,G.E. (1997) The structures of thymidine kinase from herpes simplex virus type 1 in complex with substrates and a substrate analogue. Protein Sci., 6, 2097-2106.
26. Zhou,H.B., Sheng,S., Compton,D.R., Kim,Y., Joachimiak,A., Sharma,S., Carlson,K.E., Katzenellenbogen,B.S., Nettles,K.W., Greene,G.L. et al. (2007) Structure-guided optimization of estrogen receptor binding affinity and antagonist potency of pyrazolopyrimidines with basic side chains. J. Med. Chem., 50, 399-403.
27. Maeda,M. (2001) The conserved residues of the ligand-binding domains of steroid receptors are located in the core of the molecules. J. Mol. Graph Model, 19, 543-551, 601-546.
28. Evans,J.S., Lock,K.P., Levine,B.A., Champness,J.N., Sanderson,M.R., Summers,W.C., McLeish,P.J. and Buchan,A. (1998) Herpesviral thymidine kinases: laxity and resistance by design. J. Gen. Virol., 79(Pt 9), 2083-2092.
29. Pilger,B.D., Perozzo,R., Alber,F., Wurth,C., Folkers,G. and Scapozza,L. (1999) Substrate diversity of herpes simplex virus thymidine kinase. Impact Of the kinematics of the enzyme. J. Biol. Chem., 274, 31967-31973.